Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
2018 · Scientific Reports · 53 citations
https://doi.org/10.1038/s41598-018-30421-w
D
Dylan Ferreira
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
740
Citations
16
h-index
18
i10-index
Dylan Ferreira is an academic researcher from Fernando Pessoa University. The author has contributed to research in topics: Glycosylation and Glycoproteins Research & Galectins and Cancer Biology & Bladder and Urothelial Cancer Treatments. The author has an h-index of 16, co-authored 33 publications.
ORCID: 0000-0001-9224-0121Papers by this author
worksGlycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
2021 · Journal of Experimental & Clinical Cancer Research · 37 citations
https://doi.org/10.1186/s13046-021-01988-6
Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells
2025 · iScience · 7 citations
https://doi.org/10.1016/j.isci.2025.111758
E‐selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor‐prognosis signature in colorectal cancer
2024 · Molecular Oncology · 3 citations
https://doi.org/10.1002/1878-0261.13733
Coding and regulatory somatic profiling of triple-negative breast cancer in Sub-Saharan African patients
2025 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-025-94707-6
Additional file 1 of Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14759799
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat